Titre : Échelles d'évaluation en psychiatrie

Échelles d'évaluation en psychiatrie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Narcotics
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Échelles d'évaluation en psychiatrie : Questions médicales les plus fréquentes", "headline": "Échelles d'évaluation en psychiatrie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Échelles d'évaluation en psychiatrie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-14", "dateModified": "2025-03-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Échelles d'évaluation en psychiatrie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tests neuropsychologiques", "url": "https://questionsmedicales.fr/mesh/D009483", "about": { "@type": "MedicalCondition", "name": "Tests neuropsychologiques", "code": { "@type": "MedicalCode", "code": "D009483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.711.513" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Échelle abrégée d'appréciation psychiatrique", "alternateName": "Brief Psychiatric Rating Scale", "url": "https://questionsmedicales.fr/mesh/D010054", "about": { "@type": "MedicalCondition", "name": "Échelle abrégée d'appréciation psychiatrique", "code": { "@type": "MedicalCode", "code": "D010054", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.711.513.653.083" } } }, { "@type": "MedicalWebPage", "name": "Questionnaire sur l'état mental de Kahn", "alternateName": "Mental Status Schedule", "url": "https://questionsmedicales.fr/mesh/D008609", "about": { "@type": "MedicalCondition", "name": "Questionnaire sur l'état mental de Kahn", "code": { "@type": "MedicalCode", "code": "D008609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.711.513.653.574" } } } ], "about": { "@type": "MedicalCondition", "name": "Échelles d'évaluation en psychiatrie", "alternateName": "Psychiatric Status Rating Scales", "code": { "@type": "MedicalCode", "code": "D011569", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Andreas B Hofmann", "url": "https://questionsmedicales.fr/author/Andreas%20B%20Hofmann", "affiliation": { "@type": "Organization", "name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich, Switzerland." } }, { "@type": "Person", "name": "Hanna M Schmid", "url": "https://questionsmedicales.fr/author/Hanna%20M%20Schmid", "affiliation": { "@type": "Organization", "name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich, Switzerland." } }, { "@type": "Person", "name": "Mounira Jabat", "url": "https://questionsmedicales.fr/author/Mounira%20Jabat", "affiliation": { "@type": "Organization", "name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich, Switzerland." } }, { "@type": "Person", "name": "Nathalie Brackmann", "url": "https://questionsmedicales.fr/author/Nathalie%20Brackmann", "affiliation": { "@type": "Organization", "name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Forensic Psychiatry, Zurich, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Addition of a Pericapsular Nerve Group Block for Postoperative Pain Control Does Not Result in Less Narcotic Use After Hip Arthroscopy: A Systematic Review.", "datePublished": "2024-02-15", "url": "https://questionsmedicales.fr/article/38379602", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.asmr.2024.100894" } }, { "@type": "ScholarlyArticle", "name": "Analysis of trends and usage of ICD-10-CM discharge diagnosis codes for poisonings by fentanyl, tramadol, and other synthetic narcotics in emergency department data.", "datePublished": "2022-10-20", "url": "https://questionsmedicales.fr/article/36388409", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.abrep.2022.100464" } }, { "@type": "ScholarlyArticle", "name": "Use of lateral femoral cutaneous nerve blocks by landmark technique is ineffective in decreasing narcotic usage after skin grafts: A retrospective case-control study.", "datePublished": "2024-01-15", "url": "https://questionsmedicales.fr/article/38331662", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.burns.2024.01.006" } }, { "@type": "ScholarlyArticle", "name": "Pudendal nerve block decreases narcotic requirements and time spent in post-anesthesia care units in patients undergoing primary inflatable penile prosthesis implantation.", "datePublished": "2024-05-17", "url": "https://questionsmedicales.fr/article/38760570", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41443-024-00870-1" } }, { "@type": "ScholarlyArticle", "name": "Impact of the Narcotics Information Management System on Opioid Use Among Outpatients With Musculoskeletal and Connective Tissue Disorders: Quasi-Experimental Study Using Interrupted Time Series.", "datePublished": "2024-02-21", "url": "https://questionsmedicales.fr/article/38381481", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/47130" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Disciplines et activités comportementales", "item": "https://questionsmedicales.fr/mesh/D004191" }, { "@type": "ListItem", "position": 3, "name": "Tests psychologiques", "item": "https://questionsmedicales.fr/mesh/D011581" }, { "@type": "ListItem", "position": 4, "name": "Tests neuropsychologiques", "item": "https://questionsmedicales.fr/mesh/D009483" }, { "@type": "ListItem", "position": 5, "name": "Échelles d'évaluation en psychiatrie", "item": "https://questionsmedicales.fr/mesh/D011569" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Échelles d'évaluation en psychiatrie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Échelles d'évaluation en psychiatrie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Échelles d'évaluation en psychiatrie", "description": "Qu'est-ce qu'une échelle d'évaluation psychiatrique ?\nComment sont-elles utilisées dans le diagnostic ?\nQuels types de troubles peuvent être évalués ?\nQui peut administrer ces échelles ?\nSont-elles standardisées ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Narcotics&page=14#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Échelles d'évaluation en psychiatrie", "description": "Quels symptômes mesurent-elles ?\nPeuvent-elles évaluer la sévérité des symptômes ?\nComment les symptômes sont-ils notés ?\nY a-t-il des échelles pour les enfants ?\nLes symptômes peuvent-ils fluctuer ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Narcotics&page=14#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Échelles d'évaluation en psychiatrie", "description": "Peuvent-elles aider à la prévention des troubles ?\nComment sont-elles utilisées en prévention ?\nY a-t-il des échelles spécifiques pour la prévention ?\nPeuvent-elles évaluer le stress ?\nSont-elles utiles pour les populations à risque ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Narcotics&page=14#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Échelles d'évaluation en psychiatrie", "description": "Comment les échelles influencent-elles le traitement ?\nPeuvent-elles prédire la réponse au traitement ?\nSont-elles utilisées pour suivre l'évolution ?\nPeuvent-elles évaluer l'efficacité d'un traitement ?\nLes échelles sont-elles adaptées à tous les traitements ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Narcotics&page=14#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Échelles d'évaluation en psychiatrie", "description": "Quelles complications peuvent survenir sans évaluation ?\nLes échelles aident-elles à prévenir les complications ?\nPeuvent-elles identifier des comorbidités ?\nComment les complications sont-elles évaluées ?\nLes complications affectent-elles le traitement ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Narcotics&page=14#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Échelles d'évaluation en psychiatrie", "description": "Quels facteurs de risque sont évalués ?\nLes échelles mesurent-elles l'impact des facteurs environnementaux ?\nPeuvent-elles identifier des comportements à risque ?\nComment les facteurs de risque influencent-ils le traitement ?\nLes facteurs de risque sont-ils modifiables ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Narcotics&page=14#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Qu'est-ce qu'une échelle d'évaluation psychiatrique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "C'est un outil pour quantifier les symptômes et évaluer l'état mental." } }, { "@type": "Question", "name": "Comment sont-elles utilisées dans le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à établir un diagnostic précis en mesurant les symptômes." } }, { "@type": "Question", "name": "Quels types de troubles peuvent être évalués ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent évaluer des troubles comme la dépression, l'anxiété, et la schizophrénie." } }, { "@type": "Question", "name": "Qui peut administrer ces échelles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être administrées par des professionnels de santé qualifiés." } }, { "@type": "Question", "name": "Sont-elles standardisées ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent standardisées pour assurer la fiabilité des résultats." } }, { "@type": "Question", "name": "Quels symptômes mesurent-elles ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Elles mesurent des symptômes comme l'humeur, l'anxiété, et les comportements." } }, { "@type": "Question", "name": "Peuvent-elles évaluer la sévérité des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles évaluent la sévérité des symptômes pour guider le traitement." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils notés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes sont notés sur une échelle numérique ou descriptive." } }, { "@type": "Question", "name": "Y a-t-il des échelles pour les enfants ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines échelles sont spécifiquement conçues pour les enfants et adolescents." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils fluctuer ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon les circonstances et le temps." } }, { "@type": "Question", "name": "Peuvent-elles aider à la prévention des troubles ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent identifier des symptômes précoces et aider à la prévention." } }, { "@type": "Question", "name": "Comment sont-elles utilisées en prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour détecter des signes précoces et orienter les interventions." } }, { "@type": "Question", "name": "Y a-t-il des échelles spécifiques pour la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certaines échelles sont spécifiquement conçues pour évaluer le risque de troubles." } }, { "@type": "Question", "name": "Peuvent-elles évaluer le stress ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines échelles mesurent le stress, un facteur de risque pour les troubles." } }, { "@type": "Question", "name": "Sont-elles utiles pour les populations à risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont particulièrement utiles pour les populations à risque élevé." } }, { "@type": "Question", "name": "Comment les échelles influencent-elles le traitement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à adapter le traitement en fonction de l'évolution des symptômes." } }, { "@type": "Question", "name": "Peuvent-elles prédire la réponse au traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certaines échelles peuvent aider à prédire la réponse au traitement en cours." } }, { "@type": "Question", "name": "Sont-elles utilisées pour suivre l'évolution ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour suivre l'évolution des symptômes au fil du temps." } }, { "@type": "Question", "name": "Peuvent-elles évaluer l'efficacité d'un traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent d'évaluer l'efficacité des interventions thérapeutiques." } }, { "@type": "Question", "name": "Les échelles sont-elles adaptées à tous les traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être adaptées à divers traitements, mais pas tous les types." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans évaluation ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Sans évaluation, des complications comme l'aggravation des symptômes peuvent survenir." } }, { "@type": "Question", "name": "Les échelles aident-elles à prévenir les complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent d'identifier les problèmes avant qu'ils ne s'aggravent." } }, { "@type": "Question", "name": "Peuvent-elles identifier des comorbidités ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines échelles peuvent aider à identifier des comorbidités psychiatriques." } }, { "@type": "Question", "name": "Comment les complications sont-elles évaluées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont évaluées par des scores et des descriptions des symptômes associés." } }, { "@type": "Question", "name": "Les complications affectent-elles le traitement ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent nécessiter des ajustements dans le traitement." } }, { "@type": "Question", "name": "Quels facteurs de risque sont évalués ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs de risque incluent l'hérédité, le stress et les antécédents médicaux." } }, { "@type": "Question", "name": "Les échelles mesurent-elles l'impact des facteurs environnementaux ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent évaluer l'impact des facteurs environnementaux sur la santé mentale." } }, { "@type": "Question", "name": "Peuvent-elles identifier des comportements à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines échelles peuvent identifier des comportements à risque liés à la santé mentale." } }, { "@type": "Question", "name": "Comment les facteurs de risque influencent-ils le traitement ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent influencer le choix du traitement et la stratégie d'intervention." } }, { "@type": "Question", "name": "Les facteurs de risque sont-ils modifiables ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certains facteurs de risque, comme le stress, peuvent être modifiés par des interventions." } } ] } ] }

Sources (138 au total)

The Addition of a Pericapsular Nerve Group Block for Postoperative Pain Control Does Not Result in Less Narcotic Use After Hip Arthroscopy: A Systematic Review.

To perform a systematic review of clinical studies evaluating the pericapsular nerve group (PENG) block in patients undergoing hip arthroscopy.... A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to identify comparative studies of patients undergoing the PENG block b... Five studies (2 Level I, 3 Level III) met inclusion criteria. The 5 studies included the following comparison groups: 0.9% normal saline injection, general anesthesia alone, and general anesthesia wit... Systematic review of randomized controlled trials shows that patients undergoing hip arthroscopy who receive a PENG block do not consume fewer opioids for postoperative pain control than patients who ... Level III, systematic review of Level I-III studies....

Use of lateral femoral cutaneous nerve blocks by landmark technique is ineffective in decreasing narcotic usage after skin grafts: A retrospective case-control study.

Cutaneous burns are commonly treated with autologous skin grafts. Following skin grafting, many patients complain of pain at the donor site. Donor sites are taken most commonly from the lateral thigh,... Our group began utilizing LFCN blocks in 2019. Utilizing anatomic landmarks, LFCN blocks were performed on all patients who received autologous skin grafts to reduce perioperative pain. A retrospectiv... Chart review identified 55 patients in the 2020 cohort. Fifty-five patients from the 2016 cohort were matched based upon size of skin graft, total body surface area (TBSA) burned, gender, and age. The... Our data shows that use of LFCN block by landmark technique did not reduce narcotic usage in patients that undergo skin grafting procedures. Future studies should consider ultrasound-guided LFCN block...

Impact of the Narcotics Information Management System on Opioid Use Among Outpatients With Musculoskeletal and Connective Tissue Disorders: Quasi-Experimental Study Using Interrupted Time Series.

Opioids have traditionally been used to manage acute or terminal pain. However, their prolonged use has the potential for abuse, misuse, and addiction. South Korea introduced a new health care IT syst... This study aimed to assess the impact of NIMS on opioid use.... We conducted an analysis using national claims data from 45,582 patients diagnosed with musculoskeletal and connective tissue disorders between 2016 and 2020. Our approach included using an interrupte... During the study period, there was a general trend of increasing opioid use. After the implementation of NIMS, significant increases were observed in the trend of the proportion of patients on high-do... This study suggests that, in its current form, the NIMS may not have brought significant improvements to the identified indicators of opioid overuse and misuse. Additionally, the COVID-19 outbreak exh...

Trends in hospital admission related to poisoning by, narcotics and psychodysleptics and poisoning by antiepileptic, sedative-hypnotic, and antiparkinsonism drugs in England and Wales between April 1999 and April 2020: An ecological study.

This study aimed to investigate the trend of hospital admissions related to poisoning by narcotics and psychodysleptics and poisoning by antiepileptic, sedative-hypnotic, and antiparkinsonism drugs in... An observational ecological study were conducted using data from the Hospital Episode Statistics database in England and the Patient Episode Database for Wales. The rate of hospital admissions with 95... The total annual number of hospital admissions for narcotics and psychodysfunctionals poisonings increased by 1.40-fold [from 15.70 (95% CI 15.36-16.04) in 1999 to 37.64 (95% CI 37.15-38.13) in 2020 p... Poisoning by narcotics have increased in England and Wales over the study period, however, poisoning by antiepileptic, sedative-hypnotic, and antiparkinsonism drugs in England and Wales were relativel...

Association Between Patient Reported Outcomes Measurement Information System Physical Function With Postoperative Pain, Narcotics Consumption, and Patient-Reported Outcome Measures Following Lumbar Microdiscectomy.

Retrospective cohort study.... To determine association between preoperative Patient-Reported Outcomes Measurement Information System Physical Function (PROMIS-PF) scores with postoperative pain, narcotics consumption, and patient-... Consecutive patients who underwent single-level lumbar microdiscectomy were identified from May 2017-May 2020. Patients were grouped by their preoperative PROMIS-PF scores: mild disability (score≥40),... A total of 127 patients were included. Patients with greater disability reported higher inpatient maximum Visual Analog Scale (VAS) pain scores (... Patients with greater preoperative disability, as measured by PROMIS-PF, had increased inpatient postoperative pain and narcotics consumption, but also higher improvement from baseline in long-term PR...

Preoperative Pericapsular Nerve Group Block Results in Less Pain, Decreased Narcotic Use, and Quicker Discharge Time Than No Block in Patients Who Were Surgically Treated for Femoroacetabular Impingement Syndrome.

To determine the effectiveness of pericapsular nerve group (PENG) block for patients surgically treated for femoroacetabular impingement syndrome (FAIS).... Consecutive patients who underwent surgical treatment of FAIS either with or without preoperative PENG block by a single surgeon were retrospectively identified. Twenty-five patients who received PENG... Twenty-five patients undergoing a PENG block and 25 patients who did not undergo a block (NB) were identified. No significant differences observed between age, sex, body mass index, surgery time, or p... For patients undergoing hip arthroscopy for FAIS, the addition of a preoperative PENG block showed a significant decrease in initial PACU pain, PACU narcotic consumption, intraoperative fentanyl usage... III, retrospective cohort study....